AAX Biotech Featured in Ventures Accelerated Interview at NLSDays 2025

AAX Biotech was featured in an interview with Ventures Accelerated during the Nordic Life Science Days (NLSDays) 2025 conference in Gothenburg. The company was also a finalist in the Nordic Star Pitch Competition.

In the interview, AAX Biotech's Chief Business Officer, Maria L. Knudsen, discussed the company's Seqitope® and Opti-mAb® platforms. These solutions aim to accelerate the development of next-generation antibody therapeutics and reduce potential failures in the drug development process.

Knudsen highlighted the importance of NLSDays for making connections and raising the company's international profile, noting its value as a platform for networking with peers.

AAX Biotech is now focusing on expanding collaborations, further innovating its platforms, and preparing for its next funding round, signaling anticipated growth and development.